Follow us on social media for our latest updates. Identical twins light the way for new genetic cause of arthritis 24/01/2019 Identical twin toddlers who presented with severe arthritis helped scientists to identify the first gene mutation that can single-handedly cause a juvenile form of this inflammatory joint disease. By investigating the DNA of individual blood cells of both children and then modelling the genetic defect in a mouse model, the research team led by Adrian Liston (VIB-KU Leuven) was able to unravel the disease mechanism. Leuven experts push the boundaries of 3D microscopy 16/01/2019 Two newly developed methods will help researchers to study the 3D structure of complex surfaces and of individual neurons better than ever before. Sebastian Munck and Natalia Gunko, two expert technologists at VIB-KU Leuven, report new imaging protocols that will advance neuroscience and (bio)imaging in general. Leuven scientists tackle one immune disease after the other 20/12/2018 In two recent studies, the same team of scientists has uncovered the mechanisms underlying two distinct immunological disorders affecting both children and adults. Stephanie Humblet-Baron (VIB-KU Leuven) was the researcher at the helm of both projects. Key young talent at VIB 17/12/2018 Claude Libert (VIB-UGent Center for Inflammation Research): “Steven Timmermans is a bioinformatician in my lab. During his PhD, he has combined two key tasks: providing services to other people in the group (analyzing CHIPSeq, RNASeq and other complex datasets), and building a new research line under the guidance of Yvan Saeys and myself. He has constructed a searchable database (mousepost. be), which collects all key protein polymorphisms in all sequenced mouse strains. This groundbreaking database was recently promoted by Trends in Genetics. What I admire most in Steven is his flexibility in dealing with many different datasets and his perseverance in problem-solving. Bioinformatics expertise is crucial, but to see its daily impact on our projects is amazing. As a PhD student, Steven is first author of publications in PNAS, JCI Insight, Trends in Genetics, Mammalian Genome (twice) and shares first authorship on a PNAS paper.” An ode to our VIB summer school initiator 17/12/2018 Eight years ago, microscopist and training coordinator Chris Guérin (VIB-UGent Center for Inflammation Research) set up the VIB Summer School. The founding father’s impending retirement makes it the right time to both put him in the spotlight and celebrate the birthday of his brainchild. Belgian team secures million-dollar funding from Chan Zuckerberg Initiative 05/12/2018 Today, the Chan Zuckerberg Initiative (CZI), the philanthropic endeavor led by Facebook’s Mark Zuckerberg and his partner Priscilla Chan, announced the launch of its Neurodegeneration Challenge Network. This new network brings together experimental scientists from diverse biomedical research fields, as well as computational biologists and physicians, to understand the underlying causes of neurodegenerative disorders. European Lifestars Awards 13/11/2018 Life Star award for best EU start-up (<£30M) goes to Aelin Therapeutics! Puzzling link between miRNAs and Alzheimer’s disease 26/10/2018 A team of scientists led by Bart De Strooper (VIB-KU Leuven) set out to identify small regulatory molecules called miRNAs that are involved in the development of Alzheimer’s disease. They found a handful of candidates that were upregulated in different animal models and in patients, but their link to the disease turns out to be more puzzling than anticipated. A protective role for progranulin in frontotemporal dementia and ALS 26/10/2018 In a recent study in Molecular Neurodegeneration, researchers from VIB-KU Leuven led by prof. Philip Van Damme, reveal neuroprotective effects of progranulin against TDP-43 accumulation and neurodegeneration. The findings suggest that progranulin treatment may not only be of interest to certain patients with frontotemporal dementia, but also to patients with ALS. Biotechdag 21/10/2018 CBD @ Biotechdag Check our instagram for pictures! Pagination Previous page ‹ Previous Page 5 Page 6 Page 7 Page 8 Current page 9 Page 10 Page 11 Page 12 Page 13 Next page Next ›
Identical twins light the way for new genetic cause of arthritis 24/01/2019 Identical twin toddlers who presented with severe arthritis helped scientists to identify the first gene mutation that can single-handedly cause a juvenile form of this inflammatory joint disease. By investigating the DNA of individual blood cells of both children and then modelling the genetic defect in a mouse model, the research team led by Adrian Liston (VIB-KU Leuven) was able to unravel the disease mechanism.
Leuven experts push the boundaries of 3D microscopy 16/01/2019 Two newly developed methods will help researchers to study the 3D structure of complex surfaces and of individual neurons better than ever before. Sebastian Munck and Natalia Gunko, two expert technologists at VIB-KU Leuven, report new imaging protocols that will advance neuroscience and (bio)imaging in general.
Leuven scientists tackle one immune disease after the other 20/12/2018 In two recent studies, the same team of scientists has uncovered the mechanisms underlying two distinct immunological disorders affecting both children and adults. Stephanie Humblet-Baron (VIB-KU Leuven) was the researcher at the helm of both projects.
Key young talent at VIB 17/12/2018 Claude Libert (VIB-UGent Center for Inflammation Research): “Steven Timmermans is a bioinformatician in my lab. During his PhD, he has combined two key tasks: providing services to other people in the group (analyzing CHIPSeq, RNASeq and other complex datasets), and building a new research line under the guidance of Yvan Saeys and myself. He has constructed a searchable database (mousepost. be), which collects all key protein polymorphisms in all sequenced mouse strains. This groundbreaking database was recently promoted by Trends in Genetics. What I admire most in Steven is his flexibility in dealing with many different datasets and his perseverance in problem-solving. Bioinformatics expertise is crucial, but to see its daily impact on our projects is amazing. As a PhD student, Steven is first author of publications in PNAS, JCI Insight, Trends in Genetics, Mammalian Genome (twice) and shares first authorship on a PNAS paper.”
An ode to our VIB summer school initiator 17/12/2018 Eight years ago, microscopist and training coordinator Chris Guérin (VIB-UGent Center for Inflammation Research) set up the VIB Summer School. The founding father’s impending retirement makes it the right time to both put him in the spotlight and celebrate the birthday of his brainchild.
Belgian team secures million-dollar funding from Chan Zuckerberg Initiative 05/12/2018 Today, the Chan Zuckerberg Initiative (CZI), the philanthropic endeavor led by Facebook’s Mark Zuckerberg and his partner Priscilla Chan, announced the launch of its Neurodegeneration Challenge Network. This new network brings together experimental scientists from diverse biomedical research fields, as well as computational biologists and physicians, to understand the underlying causes of neurodegenerative disorders.
European Lifestars Awards 13/11/2018 Life Star award for best EU start-up (<£30M) goes to Aelin Therapeutics!
Puzzling link between miRNAs and Alzheimer’s disease 26/10/2018 A team of scientists led by Bart De Strooper (VIB-KU Leuven) set out to identify small regulatory molecules called miRNAs that are involved in the development of Alzheimer’s disease. They found a handful of candidates that were upregulated in different animal models and in patients, but their link to the disease turns out to be more puzzling than anticipated.
A protective role for progranulin in frontotemporal dementia and ALS 26/10/2018 In a recent study in Molecular Neurodegeneration, researchers from VIB-KU Leuven led by prof. Philip Van Damme, reveal neuroprotective effects of progranulin against TDP-43 accumulation and neurodegeneration. The findings suggest that progranulin treatment may not only be of interest to certain patients with frontotemporal dementia, but also to patients with ALS.
